medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2015, Número 3

<< Anterior

Rev Invest Clin 2015; 67 (3)


Prognostic Value of Dobutamine Stress Echocardiography in Predicting Major Cardiac Events in Patients with Metabolic Syndrome

Hernández-González M, Solorio S, Solís-Jiménez MC, Rodríguez-Mariscal L, Murillo-Ortíz B, Vazquez-Olvera S

Idioma: Ingles.
Referencias bibliográficas: 26
Paginas: 199-206
Archivo PDF: 217.19 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Velázquez O, Barinagarrementería F, Rubio F, Verdejo J, Méndez MA, Violante R. [Morbidity and mortality by ischemic heart disease and stroke in Mexico. 2005]. Arch Cardiol Mex. 2007;77:31-9.

  2. García-Castillo A, Jerjes-Sánchez C, Martínez Bermúdez P, et al. RENASICA II, Mexican Registry of Acute Coronary Syndromes. Arch Cardiol Mex. 2005;75(Suppl 1):S6-19.

  3. Grima Serrano A, León Latre M, Ordoñez Rubio B. [Metabolic syndrome as a cardiovascular risk factor]. Rev Esp Cardiol. 2005;5(Suppl D):16-20.

  4. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA. 2002;288:2709-16.

  5. Ninomiya JK , L’Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004;109:42-46.

  6. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002;25:1790-4.

  7. Sawada SG, Segar DS, Ryan T. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation. 1991;83:1604-14.

  8. Sicari R, Picano E, Landi P. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study. J Am Coll Cardiol. 1997;29:254-60.

  9. Sitges M, Paré C, Azqueta M, et al. Feasibility and prognostic value of dobutamine-atropine stress echocardiography early in unstable angina. Eur Heart J. 2000;21:1063-71.

  10. Pierard LA, DeLandsherre CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol. 1990;15:1021-31.

  11. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-8.

  12. Douglas PS, Khandheria B, Stainback RF, et al. ACCF/ASE/ACEP/ AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. J Am Coll Cardiol. 2008;51:1127-47.

  13. Douglas PS, Hendel RC, Cummings JE, et al. ACCF/ACR /AHA/ ASE/ASNC/HRS/NASCI/RSNA/SAIP/SCAI/ SCCT /SCMR 2008 Health Policy Statement on Structured Reporting in Cardiovascular Imaging. Circulation. 2009;119:187-200.

  14. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. J Am Soc Echocardiogr. 2011;24:229-67.

  15. Arnese M, Fioretti PM, Cornel JH, Postma-Tjoa J, Reijs AE, Roelandt JR. Akinesis becoming diskinesis during high-dose dobutamine stress echocardiography: a marker of myocardial ischemia or a mechanical phenomenon? Am J Cardiol. 1994;73:896-9.

  16. Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics. 1983;39:207-15.

  17. Kuntz KM, Fleischmann KE, Hunink MGM, Douglas PS. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med. 1999;130:709-18.

  18. Kemelesh M, Campbell S, Ligler L, Meda M, Eckert GJ, Sawada S. Metabolic syndrome does not predict an increased risk of coronary disease in patients with traditional risk factors referred for stress imaging study. Metab Syndr Relat Disord. 2010;8:223-8.

  19. Mak KH, Moliterno DJ, Granger CB, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30:171-9.

  20. Franco O, Massaro J, Civil J, et al. Trajectories of entering the metabolic syndrome. The Framingham Heart Study. Circulation. 2009;120:1943-50.

  21. Cull CA, Jensen CC, Retnakaran R, Holman R. Impact of the metabolic syndrome on macrovascular and microvascular outcomes in Type 2 diabetes mellitus. Circulation. 2007;116:2119-26.

  22. Biagini E, Elhendy A, Bax JJ, Schinkel AF, Poldermans D. The use of stress echocardiography for prognostication in coronary artery disease: an overview. Curr Opin Cardiol. 2005;20:386-94.

  23. Miller TD, Hodge DO, Christian TF, et al. Effects of adjustment for referral bias on the sensitivity and specificity of single photon emission computed tomography for diagnostic of coronary artery disease. Am J Med. 2002;112:290-7.

  24. Al Badarin FJ, From AM, McCully RB, Lopez-Jimenez F. Likelihood of obstructive coronary disease in metabolic syndrome patients with abnormal stress echocardiography. In J Cardiol. 2011;152:207-11.

  25. Florkowski C, Scott R, Coope P, Moir C. Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study. Diabetes Res Clin Pract. 2001;53:113-20.

  26. Chaowalit N, Arruda A, McCully R, et al. Dobutamine stress echocardiography in patients with diabetes mellitus: Enhanced prognostic prediction using a simple risk score. J Am Coll Cardiol. 2006;47;1029-36.




2020     |     www.medigraphic.com